Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular

Quantitative F-18 FDG uptake in patients undergoing cardiac viability and sarcoid imaging and patients undergoing tumor imaging

Hatice Savas, Venkatesh Murthy, Edward Ficaro, Jeffery Meden and James Corbett
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1687;
Hatice Savas
1Radiology, Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venkatesh Murthy
1Radiology, Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Ficaro
1Radiology, Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffery Meden
1Radiology, Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Corbett
1Radiology, Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1687

Objectives PET imaging with F-18 FDG is used for the identification inflammatory heart diseases (InfHD) as well as myocardial viability. Metabolic preparation of patients (Pts) undergoing these protocols vary significantly. The objective of this study was to evaluate quantitative differences in background FDG uptake (liver and blood pool) and peak myocardial uptake in three protocols: (1) high fat preparatory diet (HFPD)+heparin used to minimize uptake in normal myocardial tissue imaging inflammatory heart disease, (2) glucose loading CLAMP in viability (VIAB) imaging, and (3) fast (FAST) preparation for tumor imaging.

Methods Study population consisted of 74 Pts including 24 with known or suspected InfHD (sarcoidosis), 29 with coronary disease for VIAB testing, and 21 with known or suspected cancer. Imaging was performed using 8-10 mCi F-18 FDG with Siemens mCT PET-CT (Siemens Medical Solutions, USA, Knoxville, TN). Images were analyzed for standardized uptake values (SUV) using Corridor4DM software (INVIA, Ann Arbor, MI). For statistical purposes, p<0.05 was considered significant.

Results Peak myocardial uptake varied widely depending on protocol and disease activity. Pts studied with HFPD+heparin had the lowest peak uptake (5.74±3.92, range 0.91-12.55), significantly lower than VIAB protocol (14.54±4.28, range 7.05-24.32, p<0.01), and lower than FAST preparation (9.4±4.3, range 1.3-17.0, p<0.05). Background uptake in blood and liver were much less variable with all three protocols although mean blood pool and liver uptake were significantly higher with both HFPD+heparin and FAST preparation compared to CLAMP, p<0.0001.

Conclusions Quantitative myocardial and background FDG uptake varies depending on disease activity and metabolic preparation. Although highly variable in the myocardium, relatively predictable patterns of background uptake were demonstrated depending on protocol. These differences may have important bearing on image interpretation and quantification.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative F-18 FDG uptake in patients undergoing cardiac viability and sarcoid imaging and patients undergoing tumor imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Quantitative F-18 FDG uptake in patients undergoing cardiac viability and sarcoid imaging and patients undergoing tumor imaging
Hatice Savas, Venkatesh Murthy, Edward Ficaro, Jeffery Meden, James Corbett
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1687;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quantitative F-18 FDG uptake in patients undergoing cardiac viability and sarcoid imaging and patients undergoing tumor imaging
Hatice Savas, Venkatesh Murthy, Edward Ficaro, Jeffery Meden, James Corbett
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1687;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular

  • Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
  • Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the 18F-Flurpiridaz Phase III Clinical Trial
  • Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
Show more Cardiovascular

MTA II: Cardiovascular (Clinical) Posters

  • Dependency of Rb-82 normal distribution on PET camera and processing
  • Imaging atherosclerosis with 18FDG PET: Measurement variation due to slice position
  • Comparison of four commercial software for the analysis of cardiac volume and ejection fraction when applied to PET ammonia images
Show more MTA II: Cardiovascular (Clinical) Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire